Abstract
Background Recently, cerebellar cognitive affective syndrome-scale (CCAS-S) was developed to assess CCAS—a syndrome in which cognitive impairment is caused by cerebellar lesions. Literature regarding CCAS in patients with stroke is scarce, and its impact on outcomes is unclear. This study aimed to evaluate CCAS in patients with acute cerebellar stroke and examine its relationship with the outcomes.
Methods Patients who experienced acute cerebellar stroke for the first time and were hospitalized in Steel Memorial Yawata Hospital within 7 days of stroke onset between April 2021 and April 2023 were included in this observational study. CCAS-S, Mini-Mental State Examination (MMSE), and Scale for the Assessment and Rating of Ataxia (SARA) scores were measured 1 week after stroke onset, and Functional Independence measure (FIM)/Barthel Index (BI) at discharge, physical function, activities of daily life (ADL), length of hospital stay, and outcome (discharge destination) were evaluated. The Mann–Whitney U test was used to compare CCAS-S scores and variables.
Results Thirteen consecutive patients with acute cerebellar stroke (9 women) and age-and sex-matched healthy controls (7 women) were included. The MMSE score was within the normal range in all patients; however, patients with stroke had a lower total CCAS-S score (median 72, interquartile range [IQR] 66–80) and a higher number of failed tests (median 4, IQR 3–5) than those of healthy controls. Significant deficits were observed in semantic fluency (p=0.008), category switching (p=0001), and similarity (p=009). Possible, probable, and definite CCAS were diagnosed in 2, 1, and 10 patients, respectively. Patients discharged home showed better SARA and FIM/BI scores but similar CCAS-S scores compared to those discharged to rehabilitation hospitals.
Conclusion CCAS along with impaired executive and language functions is frequently observed in patients with acute cerebellar stroke; however, impaired motor function, and not CCAS, influences the outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
none.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In accordance with the Declaration of Helsinki, this study was accepted by the Ethics Review Committee of Steel Memorial Yawata Hospital (approval number 20-62-02), and careful consideration was given to the handling of personal information. In addition, written informed consent was obtained from all patients before their participation in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email:tokuaki.8227{at}gmail.com
Emai:yamauchi.k{at}ns.yawata-mhp.or.jp
Email:tanaka.s{at}ns.yawata-mhp.or.jp
Email:gotou.k{at}ns.yawata-mhp.or.jp
Email:arakawa.s{at}ns.yawata-mhp.or.jp
Data Availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.